ClinicalTrials.Veeva

Menu

Health Benefits of Whole-body Vibration (VIBE-Rx)

Augusta University logo

Augusta University

Status

Enrolling

Conditions

Whole-body Vibration

Treatments

Other: Sub Acute Whole Body Vibration Training

Study type

Interventional

Funder types

Other

Identifiers

NCT05097885
1818010

Details and patient eligibility

About

The overall goals of this pilot investigation are to determine 1) the feasibility of conducting home based WBV studies, and 2) to determine if sub-acute home based WBV can improve a) exercise capacity, b) conduit- and micro- vascular function, and c) skeletal muscle function.

Full description

Cardiovascular disease (CVD) is the leading cause of death in the world and many comorbid conditions (i.e. diabetes, obesity) can affect overall CVD risk. There is increasing interest into the role that skeletal muscle health plays in mediating CVD risk, particularly in metabolic disease states (ie. obesity and diabetes). Whole body vibration (WBV) has emerged as an exercise mimetic that may be more tolerable than traditional modes of exercise, such as treadmill walking/running or cycling. Similar to traditional exercise modalities, WBV can elicit beneficial metabolic effects. In fact, a single bout of WBV increases circulating concentrations of IL-6, which correspond with the normalization of glucose and insulin in obese individuals. The proposed pilot investigation will provide the foundation to begin understanding the molecular and physiological mechanisms of how sub-acute WBV can improve overall CVD risk. We hypothesize that home based WBV will decrease CVD risk by improving skeletal muscle and vascular function via a decrease in systemic inflammation.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men and women (> 18 yrs old)
  • All races

Exclusion criteria

  • <18 years old
  • Clinical diagnosis of hepatic, cardiovascular, or renal disease
  • Diabetic complications (i.e. macrovascular, microvascular, or autonomic)
  • Pregnancy
  • Direct vasoactive medications (i.e. nitrates)

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Sub Acute (12 week) Whole Body Training
Experimental group
Treatment:
Other: Sub Acute Whole Body Vibration Training

Trial contacts and locations

1

Loading...

Central trial contact

Ryan Harris, PhD; Jacob Looney, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems